306 related articles for article (PubMed ID: 19895638)
1. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes.
Perwitz N; Wenzel J; Wagner I; Büning J; Drenckhan M; Zarse K; Ristow M; Lilienthal W; Lehnert H; Klein J
Diabetes Obes Metab; 2010 Feb; 12(2):158-66. PubMed ID: 19895638
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.
Tedesco L; Valerio A; Cervino C; Cardile A; Pagano C; Vettor R; Pasquali R; Carruba MO; Marsicano G; Lutz B; Pagotto U; Nisoli E
Diabetes; 2008 Aug; 57(8):2028-36. PubMed ID: 18477809
[TBL] [Abstract][Full Text] [Related]
3. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
Hsiao WC; Shia KS; Wang YT; Yeh YN; Chang CP; Lin Y; Chen PH; Wu CH; Chao YS; Hung MS
Diabetes Obes Metab; 2015 May; 17(5):495-504. PubMed ID: 25656402
[TBL] [Abstract][Full Text] [Related]
4. Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity.
Boon MR; Kooijman S; van Dam AD; Pelgrom LR; Berbée JF; Visseren CA; van Aggele RC; van den Hoek AM; Sips HC; Lombès M; Havekes LM; Tamsma JT; Guigas B; Meijer OC; Jukema JW; Rensen PC
FASEB J; 2014 Dec; 28(12):5361-75. PubMed ID: 25154875
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
Ge Q; Maury E; Rycken L; Gérard J; Noël L; Detry R; Navez B; Brichard SM
Int J Obes (Lond); 2013 Jun; 37(6):874-80. PubMed ID: 22868830
[TBL] [Abstract][Full Text] [Related]
6. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
[TBL] [Abstract][Full Text] [Related]
7. CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction.
Lipina C; Vaanholt LM; Davidova A; Mitchell SE; Storey-Gordon E; Hambly C; Irving AJ; Speakman JR; Hundal HS
Aging Cell; 2016 Apr; 15(2):325-35. PubMed ID: 26757949
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes.
Gary-Bobo M; Elachouri G; Scatton B; Le Fur G; Oury-Donat F; Bensaid M
Mol Pharmacol; 2006 Feb; 69(2):471-8. PubMed ID: 16282221
[TBL] [Abstract][Full Text] [Related]
9. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation.
Barbatelli G; Murano I; Madsen L; Hao Q; Jimenez M; Kristiansen K; Giacobino JP; De Matteis R; Cinti S
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1244-53. PubMed ID: 20354155
[TBL] [Abstract][Full Text] [Related]
10. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
[TBL] [Abstract][Full Text] [Related]
12. Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice.
Chen B; Hu N
Braz J Med Biol Res; 2017 May; 50(6):e6141. PubMed ID: 28492810
[TBL] [Abstract][Full Text] [Related]
13. Thermogenically competent nonadrenergic recruitment in brown preadipocytes by a PPARgamma agonist.
Petrovic N; Shabalina IG; Timmons JA; Cannon B; Nedergaard J
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E287-96. PubMed ID: 18492776
[TBL] [Abstract][Full Text] [Related]
14. Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes.
Choi JH; Yun JW
Nutrition; 2016 Sep; 32(9):1002-10. PubMed ID: 27133810
[TBL] [Abstract][Full Text] [Related]
15. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.
Paszkiewicz RL; Bergman RN; Santos RS; Frank AP; Woolcott OO; Iyer MS; Stefanovski D; Clegg DJ; Kabir M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927872
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.
Crespillo A; Suárez J; Bermúdez-Silva FJ; Rivera P; Vida M; Alonso M; Palomino A; Lucena MA; Serrano A; Pérez-Martín M; Macias M; Fernández-Llébrez P; Rodríguez de Fonseca F
Biochem J; 2011 Jan; 433(1):175-85. PubMed ID: 20955176
[TBL] [Abstract][Full Text] [Related]
17. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin negatively impacts insulin signaling, glucose uptake and uncoupling protein-1 in brown adipocytes.
García-Casarrubios E; de Moura C; Arroba AI; Pescador N; Calderon-Dominguez M; Garcia L; Herrero L; Serra D; Cadenas S; Reis F; Carvalho E; Obregon MJ; Valverde ÁM
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1929-1941. PubMed ID: 27686967
[TBL] [Abstract][Full Text] [Related]
19. Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.
Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C
Synapse; 2014 Mar; 68(3):89-97. PubMed ID: 24293119
[TBL] [Abstract][Full Text] [Related]
20. Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice.
Mohapatra J; Sharma M; Singh S; Pandya G; Chatterjee A; Balaraman R; Patel PR; Jain MR
J Pharm Pharmacol; 2009 Nov; 61(11):1493-8. PubMed ID: 19903374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
